Scarica l'app Stockscreener
166.28
0.78%
1.29
Dopo l'orario di chiusura:
166.27
-0.010
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
AbbVie Inc. (NYSE:ABBV) Short Interest Up 12.1% in October - MarketBeat
AbbVie snaps eight straight sessions of losses - Seeking Alpha
AbbVie (NYSE:ABBV) Trading Up 0.2%Time to Buy? - MarketBeat
Mawer Investment Management Ltd. Sells 14,746 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe - Yahoo Finance
Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products - AbbVie
Allergan Aesthetics Launches Free Business Training Platform for Healthcare Practices | ABBV Stock News - StockTitan
GLOBALT Investments LLC GA Invests $3.78 Million in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Richard C. Young & CO. LTD. - MarketBeat
Aldeyra's Dry Eye Drug Gets FDA Review, Expands $400M AbbVie Partnership Deal | ALDX Stock News - StockTitan
Aljian Capital Management LLC Invests $1.33 Million in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by MAI Capital Management - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by AMG National Trust Bank - MarketBeat
AbbVie bags EU nod for key drug from ImmunoGen takeover - pharmaphorum
AbbVie Gets European OK of Elahere in Platinum-Resistant Ovarian Cancer - MarketWatch
AbbVie’s Elahere wins European approval for certain ovarian cancers - Pharmaceutical Technology
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer - PR Newswire
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance
Atlanta Consulting Group Advisors LLC Acquires Shares of 5,060 AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sawgrass Asset Management LLC Has $13.61 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mutual of America Capital Management LLC Has $46.17 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment - MSN
Natixis Advisors LLC Has $239.62 Million Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mizuho Securities USA LLC Reduces Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mizuho Markets Americas LLC Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Dividend King AbbVie Just Paid Investors: Here's How Much They Got - 24/7 Wall St.
Kentucky Retirement Systems Insurance Trust Fund Has $10.33 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kentucky Retirement Systems Sells 10,016 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Ipswich Investment Management Co. Inc. Sells 19,650 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Coastline Trust Co - MarketBeat
Wolfe Research Initiates Coverage of AbbVie (ABBV) with Outperform Recommendation - Nasdaq
AbbVie Inc. stock underperforms Friday when compared to competitors - MarketWatch
AbbVie (NYSE:ABBV) Shares Down 1.7%Should You Sell? - MarketBeat
AbbVie Stock Falls 11% In A Month: Should You Buy The Dip? - Barchart
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? - MSN
Simplify Asset Management Inc. Takes Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Empowered Funds LLC - MarketBeat
AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades' - Benzinga
Dearborn Partners LLC Has $42.34 Million Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
CIBC Asset Management Inc Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Intellectus Partners LLC Decreases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
OneDigital Investment Advisors LLC Decreases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock - MSN
Protein Therapeutics Market Size to be Worth USD 549.4 billion by 2031, at a CAGR of 6.3% | Transparency Market Research, Inc. - GlobeNewswire Inc.
AbbVie Target of Unusually Large Options Trading (NYSE:ABBV) - MarketBeat
AbbVie Inc. stock outperforms competitors despite losses on the day - MarketWatch
AbbVie shares trade in the red for seventh straight session (NYSE:ABBV) - Seeking Alpha
ABBV: 3 Dividend Powerhouses Yielding Over 3% to Consider - StockNews.com
AbbVie Inc. (NYSE:ABBV) Shares Sold by ING Groep NV - MarketBeat
AbbVie (NYSE:ABBV) Trading Down 0.5% on Analyst Downgrade - MarketBeat
Tokio Marine Asset Management Co. Ltd. Purchases 3,304 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
William Blair Issues Positive Outlook for AbbVie Earnings - MarketBeat
KBC Group NV Boosts Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) is Hourglass Capital LLC's 2nd Largest Position - MarketBeat
AbbVie Launches Career Catalyst Award to Support 20 Professionals Living with Migraine | ABBV Stock News - StockTitan
AbbVie Inc. (NYSE:ABBV) Shares Sold by Bell Bank - MarketBeat
Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects (ALDX) - Seeking Alpha
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AbbVie (NYSE:ABBV) Trading Up 0.1%Time to Buy? - MarketBeat
Schrum Private Wealth Management LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Oppenheimer Asset Management Inc. Purchases 2,917 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Oppenheimer & Co. Inc. Has $29.38 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price - MarketBeat
Saturna Capital Corp Has $133.53 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Pinnacle Financial Partners Inc Purchases 4,441 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Empower Advisory Group LLC - MarketBeat
Aigen Investment Management LP Purchases Shares of 6,132 AbbVie Inc. (NYSE:ABBV) - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Acquires 4,217 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Morgan Stanley Lowers AbbVie's Target Price to $224, Maintains "Overweight" Rating (ABBV) - GuruFocus.com
AbbVie (NYSE:ABBV) Trading Up 0.5%Here's Why - MarketBeat
AbbVie Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
AbbVie (NYSE:ABBV) Price Target Lowered to $215.00 at Citigroup - MarketBeat
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio - Benzinga
BMO Capital Markets Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price - MarketBeat
0.26%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):